The ability to classify ALS, ALS-FTD, and controls based on TDP-43 pathology represents a significant advance in understanding the heterogeneity of ALS and its overlap with frontotemporal dementia. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.